SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Therapeutics (CTIC) -- Ignore unavailable to you. Want to Upgrade?


To: Ian@SI who wrote (320)11/29/2004 11:36:25 PM
From: Ian@SI  Respond to of 946
 
[4904] Mechanism of Arsenic Trioxide-Induced Apoptosis on Multiple Myeloma Cells. Session Type: Publication Only

Xiaohong Zhang, Yun Liang, Lida Su (Intr. by Jiong Hu). Hematology, Second Hospital Affiliated to Medical College, Zhejiang University, Hangzhou, Zhejiang, China

Multiple myeloma (MM) is an incurable B-cell malignancy. High-dose chemotherapy with stem cell support has achieved higher response rates than conventional therapy, but few patients remain in long-term remission. Arsenic trioxide (As2O3) is an effective treatment for acute promyelocytic leukemia. Current clinical studies are investigating arsenic as a therapeutic agent for malignancies. The mechanism of cytotoxicity inducted by As2O3 has not been known thoroughly. Constitutively activated NF-?B is a characteristic of different tumor entities including MM clones and malignant plasma cells from MM patients. It plays an important role in maintaining tumor cell proliferation and protecting cell from apoptosis. The study was to explore the possible mechanism of As2O3 effects on MM lines. Materials and methods: The human MM cell lines of KM3 and RPMI8226 were provided by Hematology Institution of Zhejiang University. The concentration of As2O3 in cell culture system was from 0.5µmol/L to 20µmol/L, 24 hours was selected as the termination point of cell culture. Cell culture without As2O3 and first-antibody-dismissed test were enrolled as controls. Both of the MM lines were treated with As2O3 in various concentrations. The restrained proliferation was observed by drawing growth curve. MTT bioassay was used to examine the effect of As2O3 on cell growth and the concentration of 50% growth inhibition( IC50) calculated respectively. Apoptosis and changes of I?B-a protein was observed by flow cytometry(FCM). Changes and subcellular localization of I?B-a protein were observed by fluorescence microscopy. Western blot was also used to analyze the expression of NF-?B in nuclear. Results: As2O3 inhibited the proliferation of both MM lines, and IC50 of KM3 and RPMI8226 was 9.61µmol/L and 8.01µmol/L respectively. After exposure to As2O3 , both of the lines were induced to apoptosis. With As2O3 concentration varied from 0.5µmol/L to 20µmol/L the apoptosis rate of KM3 and RPMI8226 was concentration-dependent measured by FCM. After 24 hours treated with 20µmol/L As2O3 , the apoptosis rate of KM3 cells was 41.18% while that of RPMI8226 was 65.25%. It seemed that RPMI8226 cell was more sensitive to As2O3. FCM analysis showed a significant increase in the percentage of G2/M phase cells, from 13.74% to 41.72%, and a decrease percentage of S phase cells from 35.11% to 23.96%. The level of I?B-a in cytoplasm was down-regulated after As2O3 stimulation in both cell lines. The down-regulation of I?B-a from 79.68% to 51.57% was confirmed by FCM in KM3 treated with 10µmol/L As2O3 (p<0.01), the effect was concentration-dependent. While the I?B-a in RPMI8226 changed from 79.72% to 34.08% (p<0.01). Immunofluorescence assay showed that I?B-a localized in cytoplasm mostly. The level of I?B-a protein was down-regulated after As2O3 stimulation. The results showed that KM3 and RPMI8226 lines expressed constitutively activity NF-?B and As2O3 down-regulated the constitutive expression of NF-?B in both cell lines but with different kinetics. Conclusions: As2O3 could not only inhibit the proliferation but also induce apoptosis of KM3 and RPMI8226 cells. The mechanisms of its effect on MM cells may include decreasing the constitutive activity of NF-?B, subsequently down-regulating the expression of various gene products controlled by NF-?B, thus inducing apoptosis in MM cells. As2O3 could inhibit the proliferation of MM cells by changing MM cell cycle and inducing G2/M phase arrest.
Abstract #4904 appears in Blood, Volume 104, issue 11, November 16, 2004
Keywords: Multiple myeloma|Apoptosis|Arsenic trioxide

Publication Only